Chronic Low Back Pain Clinical Trial
Official title:
The Incidence of Chronic Headache and Low Back Pain After Accidental Dural Puncture (ADP) With a Tuohy Needle and Epidural Blood Patch in the Obstetric Population: A Prospective 2-group Cohort Multicentre Study
Post Dural Puncture Headache (PDPH) causes significant short-term disability, prevents mobilisation, affects childcare activities and results in prolonged hospital stay. Initial treatment involves painkillers and if patient fails to respond, an Epidural Blood Patch (EBP). EBP involves taking patient's blood and injecting into the epidural space. It is generally agreed that PDPH is a self-limiting condition and resolves in two weeks. However there is emerging evidence that patients with PDPH could be at an increased risk of developing longstanding (chronic) headaches. Retrospective case studies show that between 28 - 34% of patients who developed PDPH had longstanding headaches at 18 months after the insertion of the epidural. There is also recent evidence of new onset low back pain developing in patients who have received an epidural blood patch that was performed to treat PDPH. Nearly two thirds of patients from a hospital in UK had new onset low back pain after they had received epidural blood patch treatment. Presently, there is no prospective clinical study evaluating the development of longstanding headaches and new onset low back pain after the development of PDPH. Aim of the present study is to evaluate the incidence of longstanding headache after accidental dural (ADP) puncture and the incidence of new onset low back pain after epidural blood patch treatment.
Headache can be a complication after insertion of an epidural needle for pain relief during
labour. The headache is called Post Dural Puncture Headache (PDPH). PDPH causes significant
short-term disability, prevents mobilisation, affects childcare activities and results in
prolonged hospital stay. Initial treatment involves painkillers and if patient fails to
respond, an Epidural Blood Patch (EBP). EBP involves taking patient's blood and injecting
into the epidural space. It is generally agreed that PDPH is a self-limiting condition and
resolves in two weeks. However there is emerging evidence that patients with PDPH could be at
an increased risk of developing longstanding (chronic) headaches. Retrospective case studies
show that between 28 - 34% of patients who developed PDPH had longstanding headaches at 18
months after the insertion of the epidural. There is also recent evidence of new onset low
back pain developing in patients who have received an epidural blood patch that was performed
to treat PDPH. Nearly two thirds of patients from a hospital in UK had new onset low back
pain after they had received epidural blood patch treatment. Presently, there is no
prospective clinical study evaluating the development of longstanding headaches and new onset
low back pain after the development of PDPH.
Aim of the present study is to evaluate the incidence of longstanding headache after
accidental dural (ADP) puncture and the incidence of new onset low back pain after epidural
blood patch treatment.
Methods: The proposed study is a prospective, cohort study that will be conducted at six
centres (Leicester, Derby, Bradford, Colchester, Bedford and Cambridge) over 36 months. Index
participants who suffer ADP will be matched with control participants who have received an
uneventful epidural insertion. The index and control participants will be matched for age,
body weight, parity and the type of delivery. Mothers who have longstanding headache or low
back pain will be excluded form the study. After providing written consent, the participants
will be provided with a questionnaire pack containing three sets of two questionnaires to be
completed at 6, 12 and 18 months after developing the headache as well as stamped envelopes
to return the questionnaires to the research team. A research team member will perform
telephone follow up 6, 12 and 18 months to encourage completion of the questionnaires.
Participation in the study will end at 18 months after completion of the study
questionnaires.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |